• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-HCV II; ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-HCV II; ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS Back to Search Results
Catalog Number 07026889190
Medical Device Problem Codes False Positive Result (1227); High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/17/2025
Type of Reportable Event Malfunction
Event or Problem Description
The initial reporter stated they received discrepant results for one patient sample tested with elecsys anti-hcv ii on a cobas e 801 analytical unit.The customer stated that the patient sample initially resulted in an anti-hcv value of 3 coi (reactive) and it repeated as 3 coi (reactive).Specific raw data was provided for an anti-hcv value of 3.4 coi (reactive).The sample was repeated using the abbott anti-hcv method on (b)(6) 2025, resulting in a value of 0.11 s/co (non-reactive).
 
Additional Manufacturer Narrative
The serial number of the e 801 analyzer is (b)(6).Calibration data from (b)(6) 2025 was within expected ranges.The investigation is ongoing.
 
Additional Manufacturer Narrative
Calibration data provided from after the event was within expected ranges.Quality controls were within expected ranges.A review of alarm trace data showed no relevant alarms.Instrument checks were acceptable.False reactive results may occur in elecsys anti-hcv ii, as the labeled assay specificity is < 100%.All initially reactive or borderline samples should be retested in duplicate using the elecsys anti-hcv ii assay.Confirmation is via supplemental methods.If one or both measurements remain borderline the analysis of a follow-up sample is recommended.Or diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.The elecsys anti-hcv ii assay performs within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-HCV II
Common Device Name
ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key23568399
Report Number1823260-2025-04662
Device Sequence Number10128893
Product Code MZO
UDI-Device Identifier04015630939947
UDI-Public04015630939947
Combination Product (Y/N)N
Initial Reporter CountryGT
PMA/510(K) Number
P140021
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2026
Device Catalogue Number07026889190
Device Lot Number823050
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/28/2025
Supplement Date Received by Manufacturer12/08/2025
Initial Report FDA Received Date11/17/2025
Supplement Report FDA Received Date12/18/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age30 YR
Patient SexMale
-
-